Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Various studies have reported a variable prevalence of disease, with an estimated incidence of 1.3/100,000, which increased over a period of time, and a prevalence of 13.3/100,000 (Peters et al., 2013)
Int J Econ Plants
1000s of regulations
The treatment difference of 17.3 percentage points versus placebo represents the largest weight reduction achieved by any pharmacotherapy in a Phase 3 trial
Mol Cell Biochem (1997) 166:3544
Phase 2 clinical trials on stasis and pressure ulcers demonstrated that thymosin beta-4 accelerated healing by almost a month compared to placebo
US$ 26.28
US$ 22.64
US$ 22.68
US$ 22.89
US$ 21.05
